Article

Cell-specific delivery of a chemotherapeutic to lung cancer cells

Center for Biomedical Inventions and Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9185, USA.
Journal of the American Chemical Society (Impact Factor: 11.44). 01/2005; 126(48):15656-7. DOI: 10.1021/ja0446496
Source: PubMed

ABSTRACT We report that lung cancer-targeting peptides isolated from a peptide library can be used to deliver an active chemotherapeutic in a cell-specific fashion. The peptides were removed from the context of the phage and placed on a pegylated tetrameric scaffold. The tetrameric peptides were shown to block uptake of their cognate phage. The tetrameric peptides were coupled to doxorubicin, and their cytotoxicity against a panel of different cell lines was tested. Our data demonstrate that these targeting peptides can deliver an active anticancer agent in a cell-specific fashion, resulting in an increase of the therapeutic index of the targeted drug compared to systemic delivery. The efficacy of the peptide conjugate correlates to the affinity of the targeting peptide for a particular cell line. As such, we have demonstrated that cell-specific targeted drugs can be synthesized, even when the cell surface target is unknown.

Download full-text

Full-text

Available from: Michael Joseph Mcguire, Sep 01, 2015
0 Followers
 · 
145 Views
 · 
108 Downloads
  • [Show abstract] [Hide abstract]
    ABSTRACT: By methods of differential-thermal analysis and X-ray-phase analysis it is proved that the Bi2Te3-Bi2Se3 section is a system with a continuous series of solid solutions, with the formation of Bi2Te2Se compound below the solidus line. The formation of this compound has been confirmed both in experiment and by thermodynamic analysis. It has been found that after zone melting the temperature values of the liquidus and solidus lines correlate with those obtained for equilibrium systems and mentioned in the literature. The boundary has been identified for the existence of Bi2Te3-xSex solid solutions, which lies at ∼14 mole % Bi2Se3 (Bi2Te2.58Se0.42). Thermodynamic analysis shows chemical interactions (reactions) resulting in the formation of Bi2Te2Se. It has been found that in the two-phase zone, the Seebeck coefficient values dramatically change in a jumping manner, with the points of extremum located on the boundaries of the two-phase zone. In the zone of Bi2Te2Se compound occurrence (33.3 mole % Bi2Se3) the values of the Seebeck coefficient and power factor are minimal.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Strategies for restoring beta-cell function in diabetic patients would be greatly aided by the ability to target genes, proteins, or small molecules specifically to these cells. Furthermore, the ability to direct imaging agents specifically to beta-cells would facilitate diagnosis and monitoring of disease progression. To isolate ligands that can home to beta-cells in vivo, we have panned a random phage-displayed 20-mer peptide library on freshly isolated rat islets. We have isolated two 20-mer peptides that bind to islets ex vivo. One of these peptides preferentially homes to the islets of Langerhans in a normal rat with clear differentiation between the endocrine and exocrine cells of the pancreas. Furthermore, this peptide does not target beta-cells in a type 2 diabetes animal model, suggesting that the peptide can discriminate between glucose-stimulated insulin secretion-functional and -dysfunctional beta-cells.
    Diabetes 08/2005; 54(7):2103-8. DOI:10.2337/diabetes.54.7.2103 · 8.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: An important goal in medicine is the development of methods for cell-specific targeting of therapeutic molecules to pathogens or pathogen-infected cells. However, little progress has been made in cell-specific targeting of bacterially infected cells. Using a phage display approach, we have isolated a 20-mer peptide that binds to Mycoplasma arginini infected pancreatic beta-cells in tissue culture. This peptide binds to M. arginini infected beta-cells 200 times better than a control phage and is specific for the infected cells. Furthermore, transferring the M. arginini contamination to another cell line renders the newly infected cell line susceptible to peptide binding. Immunolocalization experiments suggest that the peptide is binding to M. arginini adhered to the cell surface. The free synthetic peptide retains its binding in the absence of the phage vehicle and tetramerization of the peptide increases its affinity for the infected cells. Efforts have been made to use this peptide to eliminate Mycoplasma from infected cell lines using ferromagnetic beads coated with the selected peptide. A ten-fold reduction of infection was accomplished with one fractionation via this approach. Our results suggest that this peptide, isolated from an unbiased selection, may be of utility for the detection and reduction of Mycoplasma infection in cultured cells. Furthermore, a general implication of our findings is that phage display methods may be useful for identifying peptides that target a broad array of other biological pathogens in a specific fashion.
    Molecular BioSystems 08/2005; 1(2):149-57. DOI:10.1039/b504572j · 3.18 Impact Factor
Show more